News

FDA commissioner: No ‘preconceived plans’ on policy changes for abortion drug
Food and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on ...
FDA chief has no 'plans' for abortion pill policy changes but continues safety review
Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...
FDA Head To ‘Listen To Concerns’ Regarding Coerced Use Of Abortion Pill Widely Available Online
Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...
Medical Marketing & Media14h
FDA’s new national priority voucher program wants to speed up drug approvals while lowering drug costs
The FDA recently unveiled a new national priority voucher program that would seek to trade faster drug approvals for lower ...
100 days into the job, FDA head talks to CNN about agency goals— and Coke’s switch to sugar
Commissioner Marty Makary says the FDA will plow ahead with big plans on ultra process foods, dietary guidelines and ...
FDA Names Former Pharmaceutical Executive To Oversee U.S. Drug Program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
Prescription fluoride faces FDA scrutiny despite widespread support from providers and the public
The US Food and Drug Administration appears poised to continue with a plan to ban prescription fluoride supplements at a time ...
C&EN6mon
How will FDA changes reshape drug approval in 2025 and beyond?
Six weeks after a reduction in force (RIF) at the US Food and Drug Administration removed thousands of workers, signs are emerging about how the agency’s approach to drug approval may change ...
The Baltimore Sun1mon
FDA announces sweeping changes to speed up the drug review process
The Food and Drug Administration has announced some major changes to the review process for drug developers in the United States. It could cut down the time from 10 to 12 months for a review to ...
USA Today2mon
What to know about the FDA's latest COVID-19 vaccine changes - USA TODAY
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...